================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 15, 2004
BOSTON SCIENTIFIC CORPORATION
--------------------------------------------------------------------------------
(Exact name of registrant as specified in charter)
DELAWARE 1-11083 04-2695240
-------- ------- ----------
(State or other (Commission (IRS employer
jurisdiction of file number) identification no.)
incorporation)
ONE BOSTON SCIENTIFIC PLACE, NATICK, MASSACHUSETTS 01760-1537
-------------------------------------------------------------
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code: (508) 650-8000
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the fling obligation of the registrant under any of the
following provisions:
[_] Written communication pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
================================================================================
ITEM 8.01. OTHER EVENTS.
On November 15, 2004, Boston Scientific Corporation launched a public
offering of two series of its senior notes under the Company's existing shelf
registration statement. The two series of senior notes will have varied
maturities and a combined aggregate principal amount of $500 million. Boston
Scientific plans to use the proceeds to repay commercial paper borrowings and
for other general corporate purposes.
SIGNATURE
Pursuant to the requirements of the Securities and Exchange Act of 1934, as
amended, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
BOSTON SCIENTIFIC CORPORATION
Date: November 15, 2004 By: /s/ Lawrence J. Knopf
--------------------------------
Lawrence J. Knopf
Vice President and Assistant
General Counsel